摘要:
The present invention is particularly directed to the use of a derivative of vinblastine, 3',4'-anhydrovinblastine (AHVB), which differs from vinblastine in that it possesses a double bond at the 3',4' position of the caranthine nucleus rather than the hydroxyl group that is present in the parent structure, as an antineoplastic agent in the therapeutic treatment of cancer. Specifically, the treatment of lymphoma with 3',4'-anhydrovinblastine is disclosed.
摘要:
Nanoparticulate formulations for delivery of taxane conjugate prodrug formed from a taxane coupled to a hydrophobic moiety through a glycolate linker are described.
摘要:
Compositions which comprise an anthracycline agent, and a cytidine analog are encapsulated in liposomal carriers. The preferred anthracycline agent is selected from the group of daunorubicin, doxorubicin, and idarubicin, while the preferred cytidine analog is selected from the group of cytarabine, gemcitabine, or 5-azacytidine. The combination of the anthracycline agent and cytidine analog encapsulated in said liposomal carriers are useful in achieving a drug retention and a sustained drug release for each therapeutic agent.
摘要:
Compositions which comprise a liposomal water-soluble camptothecin and optionally a liposomal fluoropyrimidine in combination with a vascular epithelial growth factor (VEGF) inhibitor such as cetuximab or an epidermal growth factor receptor (EGFR) inhibitor such as bevacizumab are useful in achieving enhanced therapeutic effects for the treatment of cancer.
摘要:
Nanoparticulate formulations for delivery of taxane conjugate prodrug formed from a taxane coupled to a hydrophobic moiety through a glycolate linker are described.
摘要:
Compositions which comprise delivery vehicles having stably associated therewith a cytidine analog and a platinum agent are useful in achieving enhanced therapeutic effects when combinations of these drugs are administered.
摘要:
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of irinotecan and floxuridine. Such methods are particularly useful in the treatment of cancer patients with advanced solid tumors.
摘要:
Provided herein are methods for treating cancer by administering a pharmaceutical composition comprising a fixed, non-antagonistic molar ratio of cytarabine and an anthracycline. Such methods are particularly useful in the treatment of patients with advanced hematologic cancers or proliferative disorders.
摘要:
Compositions which comprise delivery vehicles having stably associated therewith non-antagonistic combinations of two or more agents, such as antineoplastic agents, are useful in achieving non-antagonistic effects when combinations of drugs are administered.
摘要:
A portfolio includes a rectangular piece of a canvas material having an outer peripheral edge, a rectangular peripheral piece of a vinyl material having an inner peripheral edge that slightly overlaps the outer peripheral edge of the canvas material, with an inner surface of the inner peripheral edge and an outer surface of the outer peripheral edge being heat sealed to each other with a predetermined stitching pattern, a first cardboard rigidifying member positioned to an inner surface of the canvas material corresponding to a top panel of the desk folder, a second cardboard rigidifying member positioned to an inner surface of the canvas material adjacent to the first rigidifying member, corresponding to a bottom panel of the desk folder, with a spacing between the first and second rigidifying members which defines a narrow binding edge which connects together side edges of the top and bottom panels, a vinyl backing member positioned over the first and second rigidifying members being heat sealed to the vinyl material so as to retain the rigidifying members between the backing member and the canvas material, and decorative stitching applied to an outer periphery of the portfolio.